Adare Pharmaceuticals, Inc.
Adare Pharma Solutions is a global technology-driven CDMO specializing in oral dosage forms for the pharmaceutical industry. They focus on product development and commercial manufacturing, offering specialized technologies such as taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. With a proven history, they have developed and manufactured over 65 products sold in more than 100 countries, aiming to transform drug delivery and improve patient lives.
Industries
Nr. of Employees
large (251-1000)
Adare Pharmaceuticals, Inc.
Patents
Products
Orally disintegrating tablet platform
Formulation platform for fast-dissolving oral tablets that mask taste and dissolve without water to improve adherence in patients with swallowing difficulties.
Taste-masked microencapsulation platform
Microencapsulation and coating approaches to uniformly coat API particles for taste masking while maintaining bioavailability.
Multiparticulate controlled-release platform
Multiparticulate systems (beadlets, granules, mini-tablets) for custom release profiles, high drug loading, and once-daily sustained delivery.
Precision microsphere platform for injectables
Microencapsulation-based microsphere technologies enabling tunable release kinetics for long-acting injectable products.
Solubility enhancement platform (amorphous solid dispersions)
Formulation and manufacturing methods such as spray drying to produce amorphous dispersions that improve solubility and reduce variability in absorption.
Flexible dosing beadlet/granule platform
Manufacturing processes for controlled-release beadlets and granules with narrow and uniform particle size distributions to enable flexible dosing and sprinkle applications.
Orally disintegrating tablet platform
Formulation platform for fast-dissolving oral tablets that mask taste and dissolve without water to improve adherence in patients with swallowing difficulties.
Taste-masked microencapsulation platform
Microencapsulation and coating approaches to uniformly coat API particles for taste masking while maintaining bioavailability.
Multiparticulate controlled-release platform
Multiparticulate systems (beadlets, granules, mini-tablets) for custom release profiles, high drug loading, and once-daily sustained delivery.
Precision microsphere platform for injectables
Microencapsulation-based microsphere technologies enabling tunable release kinetics for long-acting injectable products.
Solubility enhancement platform (amorphous solid dispersions)
Formulation and manufacturing methods such as spray drying to produce amorphous dispersions that improve solubility and reduce variability in absorption.
Flexible dosing beadlet/granule platform
Manufacturing processes for controlled-release beadlets and granules with narrow and uniform particle size distributions to enable flexible dosing and sprinkle applications.
Services
End-to-end CDMO services including formulation development, clinical and commercial manufacturing, and program handover to client supply chains.
Laboratory services including method development, impurity investigations, dissolution development and stability testing across temperature ranges to support regulatory submissions.
Manufacture, packaging and distribution-ready assembly of clinical trial materials with GMP and non‑GMP options, including clinical kits and labeled packs.
Managed technology transfer including data collection, analytical transfer/validation and regulatory impact assessment to enable reliable scale-up and site-to-site transfers.
Commercial packaging and serialization operations including high-speed filling lines and powder filling with global distribution support.
In-house regulatory affairs and quality management services to support global regulatory submissions, compliance and cGMP-aligned quality systems.
End-to-end CDMO services including formulation development, clinical and commercial manufacturing, and program handover to client supply chains.
Laboratory services including method development, impurity investigations, dissolution development and stability testing across temperature ranges to support regulatory submissions.
Manufacture, packaging and distribution-ready assembly of clinical trial materials with GMP and non‑GMP options, including clinical kits and labeled packs.
Managed technology transfer including data collection, analytical transfer/validation and regulatory impact assessment to enable reliable scale-up and site-to-site transfers.
Commercial packaging and serialization operations including high-speed filling lines and powder filling with global distribution support.
In-house regulatory affairs and quality management services to support global regulatory submissions, compliance and cGMP-aligned quality systems.
Expertise Areas
- Oral solid dose formulation development
- Taste-masking and pediatric-focused formulations
- Controlled-release and multiparticulate product design
- Solubility and bioavailability enhancement
Key Technologies
- Coacervation microencapsulation
- Multiparticulate and mini-tablet systems
- Amorphous solid dispersions and spray drying
- Fluid-bed coating, drying and granulation
News & Updates
Over the last two years, the Shapiro Administration has successfully competed for business, made strategic investments in key sectors of the Commonwealth’s economy, and implemented transformative changes to the permitting, licensing, and more.
The Chamber of Commerce for Greater Philadelphia has announced its new 2024-25 Board of Directors and Executive Committee Members, including Adare CEO Tom Sellig.
The investment of $2.9 million will create 115 new jobs and retain 200 existing jobs across Pennsylvania.
Adare Pharma Solutions announced a collaboration with Laxxon Medical, a pharma-technology company pioneering a new generation of solutions.
Recognized as a leader in the Small Molecule Dosage Form – Global category, highlighting their excellence in contract development and manufacturing.
Over the last two years, the Shapiro Administration has successfully competed for business, made strategic investments in key sectors of the Commonwealth’s economy, and implemented transformative changes to the permitting, licensing, and more.
The Chamber of Commerce for Greater Philadelphia has announced its new 2024-25 Board of Directors and Executive Committee Members, including Adare CEO Tom Sellig.
The investment of $2.9 million will create 115 new jobs and retain 200 existing jobs across Pennsylvania.
Adare Pharma Solutions announced a collaboration with Laxxon Medical, a pharma-technology company pioneering a new generation of solutions.
Recognized as a leader in the Small Molecule Dosage Form – Global category, highlighting their excellence in contract development and manufacturing.